Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences Inks Asia Service, Distribution Deals

NEW YORK (GenomeWeb News) – Pacific Biosciences today said that it has signed up a service provider in Asia and a distributor for its PacBio RS system in Korea.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm said that DNA Link will be the first commercial service provider for PacBio RS sequencing in Asia, as well as the first installation of the system in Korea. Seoul-based DNA Link is a contract research service provider for genomics studies.

The deal was brokered by PacBio's new distributor for Korea, Molecular Diagnostics Korea (MDxK).

Financial and other terms of the deals were not disclosed.

MDxK is PacBio's second distributor in Asia. In early November the firm said that Hong Kong-based Gene Company will distribute, market, and sell the RS instrument and related products in China and Hong Kong.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.